MedChem 2018

The final programme is available here

MedChem 2018 is an
EFMC Sponsored Event

EFMC logo

FNRS Med Chem Meeting

Should you wish to participate at the FNRS Med Chem Meeting on Thursday 22 November, please find more details here.

Conferences > Upcoming events > MedChem 2018
Friday November 23, 2018
08:00Registration
Session Chair
Dr Laurent PROVINS
(UCB, Braine-l'Alleud, Belgium)
08:50Opening
Dr Laurent PROVINS
(UCB, Braine-l'Alleud, Belgium)
09:00PL01 - Kinase Inhibitors for Non-oncological Indications: Is there a Future ?
Dr Doriano FABBRO
(PIQUR THERAPEUTICS, Basel , Switzerland)
09:50PL02 - Chemoinformatics-Driven View of Kinase Drug Discovery
(Lecture sponsored by ChemMedChem)
Prof. Jürgen BAJORATH
(UNIVERSITY OF BONN, Bonn, Germany)
10:40Coffee break and Exhibition
Session Chair
Prof. Johan WOUTERS
(UNAMUR, Namur, Belgium)
11:15OC01 - A Fast in Silico Fragment-Based Design Tool for the Discovery of Novel Kinase Inhibitors
Prof. Pascal BONNET
(UNIVERSITY OF ORLÉANS, Orléans, France)
11:35PL03 - Fragment Based Drug Discovery of Selective Inhibitors of Fibroblast Growth Factor Receptors
Dr Patrick ANGIBAUD
(JANSSEN R&D, Val de Reuil, France)
12:25Lunch, Exhibition and Poster session
Session Chair
Prof. Raphaël FREDERICK
(UCLOUVAIN, Bruxelles-Woluwé, Belgium)
14:00PL04 - Discovery, Development and In Vivo Profiling of a Novel Class of Immunosuppressive PI4KIIIβ Lipid Kinase Inhibitors
Dr James REUBERSON
(UCB, Slough, United Kingdom)
14:50OC02 - Discovery And Development Of Highly Potent And Selective FLT3 Kinase Inhibitors, A New Class of Peripheral Drugs for Treating Neuropathic Pain
Dr Claire AMIABLE
(BCI PHARMA, Montpellier, France)
15:10OC03 - Imidazo[4,5-B]Pyridine Derivatives as Potent Tam Inhibitors: From Synthesis To Cellular Imaging
Dr Sandrine PIGUEL
(INSTITUT CURIE, Orsay, France)
15:30Coffee break, Exhibition and Poster session
Session Chair
Dr Lionel POCHET
(UNAMUR, Namur, Belgium)
16:05PL05 - CDK8 Inhibitors with Pre-Engineered Long Residence Time: From Design to Tumor Xenograft Models
Dr Koen HEKKING
(MERCACHEM-SYNCOM, Nijmegen, The Netherlands)
16:45PL06 - PTEFb/CDK9 Inhibitor BAY 1251152 for the Treatment of Cancer
Dr Ulrich LÜCKING
(BAYER HEALTHCARE, Berlin, Germany)
17:35Closing Remarks
Prof. Koen AUGUSTYNS
(UNIVERSITY OF ANTWERP, Antwerp, Belgium)

Copyright 2018 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys